Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Ketorolac × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Other 1

Conditions

Rectal Neoplasms 1 Pain, Postoperative 1 Obesity 1 Inflammation 1 Ileus 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Colonic Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

Exercise 9 Psychiatric Rehabilitation 4 exemestane 3 Tamoxifen 3 Metformin 3 Early Intervention, Educational 3 Diet Therapy 3 Bariatric Surgery 3 Vitamin D 2 Therapeutics 2 Sugars 2 Specimen Handling 2 Naltrexone 2 Methods 2 Mammography 2 Letrozole 2 Diet, Mediterranean 2 Counseling 2 Cognitive Behavioral Therapy 2 Cholecalciferol 2 Bupropion 2 Blood Specimen Collection 2 Anastrozole 2 rosiglitazone-metformin combination 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Yoga 1 Walking 1 Tirzepatide 1 Testosterone Propionate 1 Testosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡